Bifidobacteria Decline: Causes and Consequences for Infant Gut Health

Jarvinen-Seppo focuses on Bifidobacterium, describing infant-type bifidobacteria — the strains that specialize in metabolizing human milk oligosaccharides (HMOs) — as traditionally considered the keystone bacteria expected to colonize the infant gut. She notes that more recent data suggest these infant-type bifidobacteria are becoming less prevalent, or in some cases disappearing, from infant guts, and that the full explanation for this shift is not yet well understood.

She returns to the factors most likely responsible: feeding type remains one of the most important drivers of bifidobacteria abundance, since formula lacks the HMOs that fuel these strains' growth. Jarvinen-Seppo also raises a historical angle, pointing out that periods of low breastfeeding rates — such as the 1960s, when breastfeeding was less common and less supported — may have had lasting effects on population-level colonization patterns that persist today. Alongside feeding history, she again highlights antibiotic exposure as a critical modern factor, since bifidobacteria are particularly vulnerable to antibiotics. Taken together, she suggests that current breastfeeding rates, the longer historical arc of feeding practices, and antibiotic use are the two factors most worth focusing on when trying to understand — and potentially reverse — the apparent decline in infant-type bifidobacteria.

In the next episode, "How Breast Milk Shapes Gut Microbiome Signaling and Immunity," Jarvinen-Seppo details the specific metabolic signals bifidobacteria send to the developing immune system, from gut pH to regulatory T cells.